Harmful algal blooms (HABs) damage human activities and health. While there is wide literature on economic losses, little is known about the economic impact on human health. In this review, we systematically retrieved papers which presented health costs following exposure to HABs. A systematic review was conducted up to January 2019 in databases such as ScienceDirect and PubMed, and 16 studies were selected. Health costs included healthcare and medication expenses, loss of income due to illness, cost of pain and suffering, and cost of death. Two categories of illness (digestive and respiratory)
INTRODUCTION
Harmful algal blooms (HABs) produce toxins that can adversely affect human health (Backer & McGillicuddy ; Figgatt et al. ) . Human exposure to harmful algae can occur in many ways (Otten & Paerl ) , i.e., through recreational water (direct or indirect contact), drinking contaminated water, or consuming food (e.g., fish Despite the known toxicity of harmful algae, the consumption of some algae (i.e., cyanobacteria) is voluntary in some cases (i.e., blue-green algae supplements) mainly due to their high protein content and some health benefits (e.g., detox, elevated mood and energy, increased alertness and vivacity) (Dietrich & , ). However, fewer are those reporting the economic consequences related to health (e.g., costs of care, economic impacts, and quality of life). This systematic review aims to report the costs and health economic consequences of contamination episodes by harmful algae including cyanobacteria. Precisely, this review aims to document the monetary costs of contamination episodes (i.e., medical consultation, hospitalization, emergency visits, drug expenditures, and loss of productivity) and the impact on health-related quality of life. We chose to do a systematic review of the literature on this topic since it is an effective way to inform decision-makers and help them make a decision based on reliable evidence (Bennett et al. ) .
METHODS

Research strategy
Databases consulted were Medline EBSCO, Scopus, ScienceDirect (Elsevier), PubMed, and the Cochrane Library. A search in the gray literature was carried out via Google, Google Scholar, and the websites of the public health agencies of Canada and Quebec. We also consulted the bibliographical references of the selected articles to collect additional relevant references. Keywords used for research were HAB, harmful algal bloom, toxin, cyanobacteria, blue-green algae, health, economic, economics, cost, QALY, and Quality-Adjusted Life Year. With the Boolean operators 'AND' and 'OR,' we made combinations between the keywords to get closer to the desired meaning. We also performed a search with the entire title of our article ('Economic impact of harmful algal bloom and cyanobacteria on human health') in Google and Google Scholar. No language or date restrictions were used. The search was carried out in English in the databases named above, then in English and French in Google, Google Scholar, and the public health agencies' internet pages. The search ended on 7 January 2019 (see Table A1 in Supplementary Material, available with the online version of this paper).
Studies' selection
In our documentary research protocol, the selection of studies was based on these criteria:
• Studies (e.g., article, review, report, and note) connected with HAB, blue-green algae, toxins, or cyanobacteria.
• Studies including health episodes, public health costs, and healthcare costs.
• Studies including an effect on health-related quality of life.
Excluded studies were those that did not include health effects (e.g., only environment and tourism). We excluded studies about the waterborne or foodborne disease which did not specifically talk about harmful algae.
The first selection of studies was made after two evaluators read the titles and summaries. Studies selected at this stage were then read in full and only kept if they met the inclusion criteria. We had no restrictions on the target population. Data extraction was done by an evaluator and validated by a second. In case of discrepancy in the data collected, a call to an arbitrator was made.
The main information we sought to collect was symptoms related to disease, frequency of healthcare consumption (e.g., consultation, emergencies, and medication), expenses related to these health episodes and the resulting loss of health-related quality of life (e.g., QALY).
Data analysis
We did a descriptive analysis of the data. Cost data were extracted and then capitalized in 2016 US dollars. If an article did not specify the year of reference for the costs, the article's year of publication was considered the reference year. For the capitalization of costs in 2016 US dollars, we used the price index available in the World Development Indicators (WDI) database of the World Bank (WB). Symptoms were grouped according to the major categories. Then, we described health episodes in terms of consultation, care, and medical monitoring. Costs associated with healthcare were calculated based on data available and the size of the sample concerned.
As appropriate, we reported the data per case, per day of sickness, or per kilometer of coastline. The quality of each study was evaluated by a grid. We used the NIH Quality Assessment Tool to evaluate primary studies (NHLBI ), AMSTAR for literature reviews (Shea et al. ) , and the grid AGREE II for reports (Brouwers et al. ) .
RESULTS
Studies' selection
The PRISMA flow diagram (Figure 1 ) presents a detailed process for selecting the articles in our systematic review.
In total, 1,524 articles were identified, and 69 were read in full to evaluate their eligibility. Ultimately, 16 studies were selected to include in this review. The reason for excluding studies that were fully read was as follows: studies reported waterborne diseases only without cost data (n ¼ 22) or general waterborne disease without linking with harmful algae (n ¼ 4); studies reported economic cost but not for health (n ¼ 6); study reported willingness to pay for harmful algae health hazard reduction (n ¼ 1); studies reported general impact (e.g., biological and ecological) of harmful algae (n ¼ 9); studies reported ocean pollution (n ¼ 2); studies reported seafood contamination (n ¼ 5) and cost of foodborne disease (n ¼ 2); study reported health episode and cost data for general waterborne illness (n ¼ 1); and study valuing protection against invasive marine species (n ¼ 1). 
Characteristics of studies included
Three main types of studies were identified as primary studies (n ¼ 9) (Table 1) , literature reviews (n ¼ 2) (Table 2) , and reports (n ¼ 5) (Table 3) . Most studies were about the United States (n ¼ 13), some on the European Union (n ¼ 2) and Canada (n ¼ 3), and two were about Pacific Ocean Islands (French Polynesia and the Cook Islands).
Data were all published in the 2000s except one study in 1995. The studies focused most often on harmful algae, without specifying the type of algae. When reported, the source of water was coastal or salt water (n ¼ 10) and freshwater (n ¼ 2). While some studies focused on costs at a national level, other costs were by the cause of illness or sick day.
Symptoms developed and health episodes
Symptoms developed
The studies retrieved in this review contain cost data related to health issues following contamination by harmful algae.
However, most of the studies do not show explicit information about symptoms developed and subsequent health episodes. This precludes documenting the impact of HABs on health-related quality of life. To document more exhaustively these symptoms and better understand their typology, we had to complete our list with additional studies. These studies were collected from the list of full-text articles assessed for eligibility. The studies selected were those that reported diseases and health episodes due to exposure to cyanobacteria and HABs. We grouped the symptoms identified into six major groups, adapted from Hilborn et al.
(), and the last one which concerns death (Table 4) Costs related to the disease Different methods were used to estimate costs associated with the disease caused by algae (Table 5) The cost of absenteeism consisted of the cost of medical treatment and the cost of lost productivity due to the illness. They also estimated the cost of presenteeism, such as the amount 
Costs of disease
In general, and according to studies, health costs can be categorized into three subgroups of costs: (direct) healthcare 
Short-and long-term costs
All the studies included only assessed costs related to acute exposure to HABs that is short-term costs observed in a relatively short period (days or weeks). No studies included costs on a long-term basis, such as costs related to chronic exposure to HABs or chronic illness that may be caused by chronic exposure to contaminated water.
Other costs
The costs of investigating sickness could also be considered in the accounting of the overall costs related to exposure to HABs. Time spent interviewing patients, epidemiological analysis of data, communication with other services and writing reports for a total estimated at $697 per case of illness, and laboratory examination costs ranged from $278 to $556 (Todd ).
Impact on health-related quality of life
In this section, we show data on health-related quality of life for the illnesses reported in Table 4 . The aim was to give an insight into how much well-being one (or a society) could lose when facing these illnesses, which may be caused by HABs. We found that breathing difficulty appeared to be the sickness which caused the most loss of QALYs in chil- people. Thus, if we suppose a specific cost of $50 K per QALY, we can find the health-related quality of life-associated cost of each disease (Poder ).
Overall cost
Having a general insight into potential health costs following exposure to HAB is important because it could help policy planning and decision-making. At the national level, the effect on public health represents the largest share of the impact of algae and is estimated to be about We carried out calculations to assess the overall burden of diseases caused by HABs. We retained two illnesses (respiratory and digestive) and death, three levels of severity (mild, moderate and severe) and 3 days of the disease, We determined that a moderate case of illness due to contamination by HAB costs around $1,000 and a mild case costs around $100 (Table 7) . The major health cost is due to fatal cases, which could be estimated at $3M. Using a small figure of 1,000 people affected each year, with 75% mild cases, 24% moderate, and 1% death, this could lead to a global burden of $30.3M each year.
DISCUSSION
Overall, reviewing the literature to address the lack of health cost data and trying to put together all these studies which had potential interest for our review led to some concern.
Unreported illness could be, by far, the most important The misleading symptoms of illness following exposure to harmful algae are also a limit. Since having flu, headache, diarrhea or fatigue, and the like may not be caused only by exposure to harmful algae; it is difficult to establish a direct and causal relationship between observed symptoms and a Authors' calculations: we combined population suffering from injury and burns and visual disturbance and assumed that their QALY lost was 5% of the total QALYs lost in the visual impairment category. There is an incapacity to measure all the costs following exposure to harmful algae, e.g., the cost of pain and suffering. Most of the studies included in our review did not consider these kinds of cost. One study (Nierenberg et al. ) discussed it but did not include it, as the authors acknowledge that they cannot estimate these costs, even if the cost of pain and suffering could be included in the calculation of QALYs lost due to harmful algae exposure. Also, since the studies included in this review provided too little information about the different kinds of HABs, it was impossible for us to estimate specific costs by the type of toxins.
There are many other studies which present costs of waterborne illness or foodborne illness that could be interesting to discuss here since they have some similarity to those about harmful algae. For example, some authors Even if these costs may be far from those used in Table 6 , the authors cited some studies (Liddle et al. ; Carabin et al. ) which found the same costs as in Table 6 . We included studies which met our inclusion criteria without considering their methodological rigor since most
were of low quality. This may be kept in mind while considering the overall results of this review. While extracting and reporting the cost data from the studies, some did not report explicitly the years in which costs are expressed. So, for the studies that did not give the year of their costs, we assumed the cost for the year of publication. The QALYs reported in Table 6 were not measured with the same tool. We had no means to make the correspondence between them. However, this provides an idea of these costs. Overall, the quality of the studies included in this review is moderate, especially for primary studies, even if reviews and reports did not match all the criteria well. Some studies were based on a population which may be concerned about water pollution, and extrapolation of the results may be done with precaution.
Illness from shellfish presented by Todd () concerned sporadic events across Canada; this is the case for Hoagland et al. () . Since it remains difficult to collect data over all the contamination cases, all studies included in this review collected data on the same population or in the same time period. This may be a concern which should be considered when it comes to generalizing the results. The fact that not all the studies are precise about the harmful algae considered creates uncertainty over to which algae one could attribute the illness. However, it
would not be easy to isolate the effect or contribution of each algae species on the disease. Finally, we found no specific study about cyanobacteria, and little is known about their impact on health and related health expenses (Donohue et al. ) .
Finally, the fact that some studies used survey and selfreported exposure and illness could create a bias in the data used for cost estimation. In fact, having contact with water did not necessary imply contamination by HA as well as having symptoms similar to those caused by algae.
In the absence of a medical diagnostic, self-reported data should be considered with caution.
CONCLUSION
This review gave specific regard to the economic impact of harmful algae on human health. We found that harmful algae could cause many health problems and generate important expenses. Having more studies which focus on the health aspects and consequences of human health could help present a better understanding of these health problems. Although this study may have some weakness due to the quality of the selected studies, it remains methodologically rigorous and could help assess human health costs due to cyanobacteria and harmful algae in general.
